Nectar Lifescience Ltd share price logo

Nectar Lifescience Ltd Share Price

NSE: NECLIFE

BSE: 532649

Small Cap

Healthcare Sector

₹16.56

+0.78

(+4.94%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Nectar Lifescience Ltd Stock Performance

as on September 15, 2025 at 4:01 pm IST

  • Day's Low

    ₹16
    ₹16.56
    downward going graph

    3.38%

    Downside

  • 52 Week's Low

    52 Week's High

    ₹13.05
    ₹56.5
    downward going graph

    21.20%

    Downside

    241.18%

    Upside

    downward going graph

Nectar Lifescience Ltd share price movements today

Previous Close
₹15.78
Open
₹16.38
Volume
7.76L
Upper Circuit
₹16.56
Lower Circuit
₹14.99
Day's Low - High
₹16 - ₹16.56
52 Week Low - High
₹13.05 - ₹56.5

Nectar Lifescience Ltd Historical Returns

1 Month Return
+ 9.6 %
3 Month Return
-29.38 %
1 Year Return
-66.12 %
3 Year Return
-30.27 %
5 Year Return
-21.89 %

Nectar Lifescience Ltd Fundamentals

as on September 15, 2025 at 4:01 pm IST

Market Cap

₹371.38 Cr

Return on Equity (ROE)

-11.23

PE Ratio (TTM)

-2.06

Return on capital employed (ROCE)

-5.33

Industry PE ratio

42.36

Beta (LTM)

0.84

P/B Ratio

0.54

Dividend Yield

0

PEG Ratio

0.25

Quarterly Earnings Growth YOY

-2228.96

EPS (TTM)

-5.07

Sector

Pharmaceuticals

Book Value

42.63

Technical Analysis

Bullish

View Technical Analysis

Nectar Lifescience Ltd Stock Valuation

as on September 15, 2025 at 4:01 pm IST

Nectar Lifescience Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-284.58x)

December 21, 2023

Today (-2.06x)

September 15, 2025

Industry (42.36x)

September 15, 2025

Highest (403.33x)

August 26, 2020

LowHigh

Today’s Price to Earnings Ratio: -2.06x

Nectar Lifescience Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nectar Lifescience Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Nectar Lifescience Ltd image
Nectar Lifescience Ltd
NA371.38-4.38%0.69-1141,669
Source Natural Foods & Herbal Supplements Ltd image
Source Natural Foods & Herbal Supplements Ltd
NA88.09-1.8%0.00127
Mono Pharmacare Ltd image
Mono Pharmacare Ltd
NA43.20-3.94%0.803168
Parnax Lab Ltd image
Parnax Lab Ltd
NA159.31157.82%0.779188
Venus Remedies Ltd image
Venus Remedies Ltd
NA605.6654.49%0.5045647
See all

Nectar Lifescience Ltd Stock's Interest Amongst Investors

Investment in Nectar Lifescience Ltd Shares on INDmoney has dropped by -33.79% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-33.79% versus previous 30 day period

Search interest for Nectar Lifescience Ltd Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-17% versus previous 30 day period

Nectar Lifescience Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
388.64
344.12
387.89
394.12
397.96
452.16
439.85
358.85
427.88
454.33
428.91
280.67
Other Income
10.71
13.24
17.92
0.47
10.61
0.48
1.47
0.55
0.69
0.57
0.08
0.35
Total Income
399.36
357.37
406.74
394.6
408.57
452.65
442.84
359.85
428.79
455.56
430.77
281.02
Expenses
396.05
342.68
370.72
358.58
371.1
409.98
392.87
319.5
384.76
410.27
585
342.56
Operating Profit
-7.41
1.44
17.17
35.54
26.86
42.18
46.98
39.35
43.12
44.06
-156.09
-61.89
Operating Profit Margin %
-1.91%
0.42%
4.43%
9.02%
6.75%
9.33%
10.68%
10.97%
10.08%
9.7%
-36.39%
-22.05%
Profit Before Interest, Tax and Depreciation
3.31
14.69
36.01
36.01
37.47
42.67
49.97
40.35
44.02
45.28
-154.23
-61.54
Interest
20.99
17.46
19.66
17.62
20.52
24.84
24.16
19.98
19.81
17.12
17.67
18.7
Depreciation
14.79
14.78
14.85
15.33
15.31
15.37
14.7
15.46
15.55
15.61
15.77
16.52
Profit Before Tax
-32.47
-17.55
1.5
3.06
1.64
2.46
11.11
4.91
8.66
12.55
-187.67
-96.76
Tax Paid
-10
-8.27
-2.17
1.24
0.63
0.89
10.52
1.95
3.07
4.71
-57.58
-33.52
Profit After Tax
-22.47
-9.29
3.68
1.82
1.02
1.57
0.59
2.97
5.6
7.84
-130.09
-63.23
Total Net profit including share of profit / Loss from associate company
-22.47
-9.29
3.68
1.82
1.02
1.57
0.59
2.97
5.6
7.84
-130.09
-63.23
EPS
-1
-0.41
0.16
0.08
0.05
0.07
0.03
0.13
0.25
0.35
-5.8
-2.82
Actual EPS
-1
-0.41
0.16
0.08
0.05
0.07
0.03
0.13
0.25
0.35
-5.8
-2.82
Adjusted EPS
-1
-0.41
0.16
0.08
0.05
0.07
0.03
0.13
0.25
0.35
-5.8
-2.82
Diluted EPS
-1
-0.41
0.16
0.08
0.05
0.07
0.03
0.13
0.25
0.35
-5.8
-2.82

Nectar Lifescience Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
1,643.7
1,876.26
2,782.86
2,366.38
1,543.3
1,668.83
1,523.67
1,684.09
1,669.97
Other Income
22.37
5.58
5.96
4.01
2.72
11.29
42.24
13.03
1.89
Total Income
1,666.36
1,882.3
2,788.9
2,370.74
1,547.09
1,680.15
1,566.85
1,698.66
1,674.97
Expenses
1,419.28
1,640.1
2,518.69
2,146.68
1,459.57
1,510.29
1,470.66
1,532.53
1,699.53
Operating Profit
224.42
236.16
264.17
219.7
83.73
158.54
53.01
151.56
-29.56
Operating Profit Margin %
13.65%
12.59%
9.49%
9.28%
5.43%
9.5%
3.48%
9%
-1.77%
Profit Before Interest, Tax and Depreciation
247.08
242.19
270.21
224.06
87.52
169.86
96.19
166.13
-24.57
Interest
117.41
115.2
148.14
125.83
112.03
78.81
79.49
87.14
74.58
Depreciation
62.25
64.31
63.26
60.77
60.25
56.97
59.12
60.72
62.39
Profit Before Tax
67.42
62.68
58.81
37.46
-84.76
34.08
-42.42
18.27
-161.54
Tax Paid
12.08
10.41
11.22
5.68
-11.5
9.03
-18.24
13.27
-47.85
Profit After Tax
55.34
52.27
47.6
31.79
-73.26
25.05
-24.18
4.99
-113.68
Total Net profit including share of profit / Loss from associate company
55.34
52.27
47.6
31.79
-73.26
25.05
-24.18
4.99
-113.68
EPS
2.47
2.33
2.12
1.42
-3.27
1.15
-1.08
0.22
-5.07
Actual EPS
2.47
2.33
2.12
1.42
-3.27
1.15
-1.08
0.22
-5.07
Adjusted EPS
2.47
2.33
2.12
1.42
-3.27
1.15
-1.08
0.22
-5.07
Diluted EPS
2.47
2.33
2.12
1.42
-3.27
1.15
-1.08
0.22
-5.07

Nectar Lifescience Ltd Cash Flow

Figures in Rupees Crores

Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Net Cash from Operating Activities
144.41
168.82
198.75
65.17
239.24
284.96
21.38
95.01
133.65
224.69
Cash Flow from Investing Activities
-60.53
-76.88
-18.11
-29.43
-26.13
-33.13
-28.62
16.64
51.71
-17.03
Cash Flow from Financing Activities
-61.47
-88.68
-204.12
-39.6
-201.09
-251.87
11.48
-119.38
-185.59
-205.44
Net Cash Flow
23.41
3.26
-23.47
-3.87
12.02
-0.03
4.25
-7.73
-0.23
2.23

Nectar Lifescience Ltd Stock Shareholding Pattern

Numbers in percentages

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Promoters
55.8%
55.8%
55.8%
55.8%
55.8%
55.8%
55.8%
55.8%
55.8%
44.53%
44.53%
44.53%
DII
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0.16%
0.19%
FII
14.59%
14.59%
14.59%
14.59%
14.59%
14.59%
16.97%
16.61%
3.24%
0.73%
1.65%
0.81%
Government
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
Public
28.06%
28.19%
28.11%
28.18%
28.16%
28.06%
27.21%
27.57%
40.94%
54.72%
53.65%
54.44%
Total Outstanding Shares
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
Total Shareholders
62,940
64,422
62,874
61,582
60,283
60,761
59,946
58,230
66,741
69,482
69,241
71,977

Nectar Lifescience Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Nectar Lifescience Ltd.

  • Nectar Lifescience Ltd Earnings Results

    Nectar Lifescience Ltd’s net profit fell -2228.96% since last year same period to ₹-63.23Cr in the Q1 2025-2026. On a quarterly growth basis, Nectar Lifescience Ltd has generated 51.4% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Nectar Lifescience Ltd Dividends July,2020

    In the quarter ending June 2020, Nectar Lifescience Ltd has declared dividend of ₹0.05 per share on 29 Jul 2020 - translating a dividend yield of 0.32%.

    Read More about Dividends

Insights on Nectar Lifescience Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -130.09 Cr → -63.23 Cr (in ₹), with an average increase of 105.7% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 53.65% to 54.44% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, NECLIFE stock has moved up by 11.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.8% return, outperforming this stock by 174.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 44.53% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 10.0% return, outperforming this stock by 77.7%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.65% to 0.81% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 455.56 Cr → 281.02 Cr (in ₹), with an average decrease of 20.1% per quarter

About Nectar Lifescience Ltd

Nectar Lifesciences Ltd (NLL or NECLIFE) is a globally acclaimed integrated pharmaceutical organization engaged in the manufacture and supply of high quality pharmaceutical products. With a vast network of production sites spread across three Indian states of Punjab, Himachal Pradesh, and Jammu, the organization provides top-notch active pharmaceutical ingredients (API), finished dosage forms, phytochemicals, and hard gelatin capsules to customers in over 90 countries across the world. In addition to manufacturing and marketing cephalosporins and phytochemicals, NECLIFE is also into contract manufacturing of APIs. Established in 1995, the organization has seen a number of expansions, the most recent being in 2019 when they established a unit in Portugal to take over marketing activities from the UK-based wing. They have also launched two new innovative products in the form of menthol capsules and pearl capsules. Focussing on providing quality products, NECLIFE has obtained approval from the Japanese MOH and is well-poised to continue its phenomenal rise in the global pharmaceuticals market.

Revenue: ₹280.67Cr as on June 2025 (Q1 FY26)
Net Profit: ₹-63.23Cr as on June 2025 (Q1 FY26)
Listing date: 18 Jul, 2005
Chairperson Name: Sanjiv Goyal
OrganisationNectar Lifescience Ltd
HeadquartersChandigarh
IndustryPharmaceuticals
CEOSanjiv Goyal
E-voting on sharesClick here to vote

FAQs

What is Nectar Lifescience Ltd share price today?

Nectar Lifescience Ltd share price today stands at ₹16.56 as on . Nectar Lifescience Ltd share today touched a day high of ₹16.56 and a low of ₹16.

What is the 52 week high and 52 week low range for Nectar Lifescience Ltd share?

Nectar Lifescience Ltd touched a 52 week high of ₹56.5 and a 52 week low of ₹13.05. Nectar Lifescience Ltd share price today i.e. is trending at ₹16.56, which is -70.69% down from its 52 week high and 26.90% up from its 52 week low.

What is Nectar Lifescience Ltd's market capitalisation today?

Nectar Lifescience Ltd market capitalisation is ₹371.38 Cr as on .

How to buy Nectar Lifescience Ltd shares?

To buy Nectar Lifescience Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for NECLIFE or Nectar Lifescience Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Nectar Lifescience Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Nectar Lifescience Ltd trading volume today?

Nectar Lifescience Ltd trading volume is 7.76L as on . This means that 7.76L shares of Nectar Lifescience Ltd were bought and sold on the stock market during today's trading session.